SS
GPCR icon

Steve Schonfeld’s Structure Therapeutics GPCR Stock Holding History

Steve Schonfeld’s Portfolio GPCR Stock Details GPCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$10.2M Buy
190,685
+25,259
+15% +$1.12M 0.04% 416
2026
Q1 		$7.97M Buy
165,426
+156,699
+1,796% +$10.7M 0.06% 353
2025
Q4 		$607K Buy
+8,727
New +$356K ﹤0.01% 1318
2025
Q3 		– Sell
-321,591
Closed -$6.67M – 2340
2025
Q2 		$6.67M Buy
+321,591
New +$7.07M 0.05% 467
2024
Q3 		– Sell
-216,413
Closed -$8.5M – 2179
2024
Q2 		$8.5M Buy
+216,413
New +$8.89M 0.05% 398
2024
Q1 		– Sell
-9,200
Closed -$375K – 2189
2023
Q4 		$375K Sell
9,200
-15,400
-63% -$883K ﹤0.01% 1368
2023
Q3 		$1.24M Buy
+24,600
New +$793K 0.01% 953

Other funds holding GPCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Steve Schonfeld's GPCR Position: Q2 2026 in Review

Steve Schonfeld increased its Structure Therapeutics (GPCR) stake by 15% in Q2 2026, buying an estimated $1.12M and bringing the position to 190,685 shares worth $10.2M. The position accounts for 0.04% of the portfolio, ranked #416.

Steve Schonfeld first reported a position in GPCR in Q3 2023 and has held it in 7 quarters since. 192 funds tracked by Wall St. Rank hold GPCR as of Q2 2026.

  • Steve Schonfeld held 190,685 shares of Structure Therapeutics worth $10.2M as of Q2 2026.
  • Steve Schonfeld bought 25,259 Structure Therapeutics shares in Q2 2026, an estimated $1.12M.
  • Structure Therapeutics made up 0.04% of Steve Schonfeld's portfolio in Q2 2026, its #416 holding.
  • Steve Schonfeld first reported a position in Structure Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • 192 funds tracked by Wall St. Rank held Structure Therapeutics as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.